Synopsis:
Main firms throughout diagnostics, renewables, petrochemicals, cybersecurity, and specialty chemical compounds have posted sturdy Q2FY26 earnings with wholesome income development, margin enlargement, and spectacular revenue good points. Do you personal any?
The Q2FY26 earnings season has kicked off on a powerful word, with firms delivering spectacular year-on-year performances throughout sectors reminiscent of diagnostics, renewables, petrochemicals, cybersecurity, and specialty chemical compounds.
Whereas total market sentiment stays cautious, the preliminary batch of outcomes factors to broad-based earnings momentum, with a number of firms posting wholesome income good points and notable enhancements in operational effectivity. Listed here are 5 shares which have stood out to this point.

Thyrocare Applied sciences Restricted is one in every of India’s main diagnostic chains, providing testing companies to sufferers, laboratories, and hospitals throughout the nation. The corporate operates by three foremost segments, Diagnostic Testing Providers, Imaging Providers, and Others.
Its diagnostic testing division focuses on the sale and promotion of consumables utilized in pathology, whereas the imaging division offers in radiopharmaceuticals and consumables for reporting.
Thyrocare additionally markets medical gear and glucometers below the model title ‘Sugarscan’. Based in 1996 and headquartered in Navi Mumbai, it operates as a subsidiary of Docon Applied sciences Non-public Restricted.
The corporate has a market capitalization of Rs. 6,677.30 crore and closed at Rs. 1,260 on Tuesday, up by 1.42 % from earlier day closing worth of Rs. 1242.30. On a year-on-year foundation, gross sales grew by 22.6 % from Rs. 177 crore in Q2FY25 to Rs. 217 crore in Q2FY26.
Web revenue rose sharply by 84.6 % from Rs. 26 crore to Rs. 48 crore. Working revenue elevated by 47.9 % from Rs. 48 crore to Rs. 71 crore, with working margins enhancing from 27 % to 33 %. Earnings per share (EPS) superior from Rs. 5.04 to Rs. 9.06.
Waaree Renewable Applied sciences Restricted is engaged within the technology of renewable energy and offers a complete vary of photo voltaic power options in India. The corporate’s companies span ground-mounted photo voltaic tasks, rooftop installations, floating photo voltaic, and operations and upkeep assist.
It additionally provides engineering, procurement, and development (EPC) options below a number of enterprise fashions, catering to industrial, business, and particular person purchasers. Previously often known as Sangam Renewables Restricted, the corporate was integrated in 1999 and is headquartered in Mumbai. It operates as a subsidiary of Waaree Energies Restricted.
The corporate has a market capitalization of Rs. 13,128.81 crore and closed at Rs. 1,259.40 on Tuesday, up by 2.04 % from earlier day closing worth of Rs. 1234.20. On a year-on-year foundation, gross sales elevated by 47.9 % from Rs. 524 crore in Q2FY25 to Rs. 775 crore in Q2FY26.
Web revenue greater than doubled, rising by 114.8 % from Rs. 54 crore to Rs. 116 crore. Working revenue jumped by 119.4 % from Rs. 72 crore to Rs. 158 crore. Working margin expanded from 14 % to twenty %, whereas EPS surged from Rs. 5.14 to Rs. 11.16.
Mangalore Refinery and Petrochemicals Restricted, a subsidiary of Oil and Pure Fuel Company Restricted, is engaged in refining and advertising and marketing petroleum merchandise in India. Its product portfolio consists of bitumen, high-speed diesel, motor gasoline, xylol, pet coke, sulphur, and polypropylene.
The corporate additionally produces and exports a spread of petrochemical and fragrant merchandise reminiscent of benzene, paraxylene, reformate, and toluene, whereas additionally working shops throughout India. Established in 1988, the corporate is headquartered in Mangalore.
The corporate has a market capitalization of Rs.26,273.21 crore and closed at Rs. 149.91 on Tuesday, down by 1.07 % from earlier day closing worth of Rs. 151.53. On a year-on-year foundation, gross sales declined by 9.3 % from Rs. 24,968 crore in Q2FY25 to Rs. 22,649 crore in Q2FY26.
Nonetheless, it delivered a outstanding turnaround in profitability, posting a web revenue of Rs. 627 crore in comparison with a lack of Rs. 697 crore within the earlier 12 months. Working revenue moved into the optimistic zone at Rs. 1,489 crore from a lack of Rs. 474 crore, with working margins enhancing considerably from adverse 2 % to 7 %. EPS stood at Rs. 3.58 in comparison with a loss per share of Rs. 3.98 final 12 months.
Additionally Learn: 1:1 Bonus shares: Inventory in focus after firm’s board approves bonus concern
Fast Heal Applied sciences Restricted develops and offers cybersecurity and knowledge safety options for people, companies, and authorities entities in India and overseas. Its product vary consists of antivirus software program, endpoint safety, cellular safety, and enterprise options below the manufacturers ‘Fast Heal’ and ‘Seqrite’.
The corporate’s choices additionally lengthen to menace intelligence, managed detection, and response companies. Based in 1995, Fast Heal is headquartered in Pune and operates throughout a number of international markets.
The corporate has a market capitalization of Rs. 1,780.18 crore and closed at Rs. 328.70 on Tuesday, up by 0.15 % from earlier day closing worth of Rs. 328.20. On a year-on-year foundation, gross sales elevated by 13.6 % from Rs. 73.49 crore in Q2FY25 to Rs. 83.52 crore in Q2FY26.
Web revenue rose by 90.6 % from Rs. 4.15 crore to Rs. 7.91 crore. Working revenue tripled, leaping 200.6 % from Rs. 3.07 crore to Rs. 9.23 crore. Working margin improved from 4.18 % to 11.05 %, whereas EPS climbed from Rs. 0.77 to Rs. 1.46.
Stallion India Fluorochemicals Restricted is concerned within the processing, mixing, and distribution of refrigerants and industrial gases throughout India. The corporate’s numerous portfolio consists of hydrocarbons (HC), hydrofluorocarbons (HFC), and hydrofluoroolefins (HFO), catering to industries reminiscent of air-con, refrigeration, firefighting, semiconductors, cars, prescribed drugs, and protection. It additionally provides gear and consumables for the AC and refrigeration trade and produces specialty gases like CF4 and SF6.
The corporate has a market capitalization of Rs. 2,818.43 crore and closed at Rs. 355.30 on Tuesday, hitting a decrease circuit of 5 % from earlier day closing worth of Rs. 374. On a year-on-year foundation, gross sales surged by 55.9 % from Rs. 68 crore in Q2FY25 to Rs. 106 crore in Q2FY26.
Web revenue elevated sharply by 1,000 % from Rs. 1 crore to Rs. 11 crore. Working revenue rose 700 % from Rs. 2 crore to Rs. 16 crore, whereas working margins expanded considerably from 3 % to fifteen %. EPS additionally improved considerably from Rs. 0.14 to Rs. 1.44.
Written By Manan Gangwar
Disclaimer

The views and funding suggestions expressed by funding consultants/broking homes/ranking companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Commerce Brains Applied sciences Non-public Restricted or the creator are usually not chargeable for any losses triggered on account of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.


Cappadocia travel package Noah S. ★★☆☆☆ Luxury cave hotel pool was under renovation (not mentioned at booking). Disappointed after 12hr flight. https://silkroadmuseumhotel.com/turkey-culture-and-historical-tours.html